Press Release: Circular Genomics : Circular Genomics Announces New Research Demonstrating Accuracy of circRNA-based Test for Predicting Response to SSRI Antidepressant Treatment
/PRNewswire/ -- Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry and neurology, today announced study results published...
Read full article »
Circular Genomics is a New Mexico-based biotech firm that develops RNA-based biomarkers and diagnostic tools for the treatment of psychiatric and neurological disorders.
Read more